Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a report issued on Saturday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Stock Performance

Shares of Enzo Biochem stock opened at $0.66 on Friday. The stock’s fifty day moving average price is $0.88 and its 200-day moving average price is $1.04. Enzo Biochem has a 12 month low of $0.63 and a 12 month high of $1.44.

Enzo Biochem (NYSE:ENZ) last issued its earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share (EPS) for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. XTX Topco Ltd boosted its position in Enzo Biochem by 94.5% during the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 13,735 shares in the last quarter. BBR Partners LLC purchased a new stake in shares of Enzo Biochem during the third quarter valued at about $112,000. Geode Capital Management LLC boosted its holdings in shares of Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after buying an additional 11,742 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in shares of Enzo Biochem by 2.6% in the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after buying an additional 64,417 shares in the last quarter. 36.90% of the stock is currently owned by hedge funds and other institutional investors.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.